GI
IDXX icon

GAMMA Investing’s Idexx Laboratories IDXX Stock Holding History

GAMMA Investing’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Buy
3,297
+229
+7% +$128K 0.06% 243
2026
Q1 		$1.72M Buy
3,068
+77
+3% +$49.4K 0.08% 220
2025
Q4 		$2.02M Buy
2,991
+264
+10% +$180K 0.1% 164
2025
Q3 		$1.74M Buy
2,727
+292
+12% +$177K 0.1% 175
2025
Q2 		$1.31M Buy
2,435
+248
+11% +$119K 0.08% 213
2025
Q1 		$918K Buy
2,187
+654
+43% +$284K 0.07% 259
2024
Q4 		$634K Buy
1,533
+49
+3% +$21.5K 0.05% 302
2024
Q3 		$750K Buy
1,484
+314
+27% +$153K 0.07% 245
2024
Q2 		$570K Buy
1,170
+575
+97% +$289K 0.08% 238
2024
Q1 		$321K Buy
595
+85
+17% +$46.5K 0.07% 280
2023
Q4 		$263K Buy
+510
New +$239K 0.07% 256

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

GAMMA Investing's IDXX Position: Q2 2026 in Review

GAMMA Investing increased its Idexx Laboratories (IDXX) stake by 7.5% in Q2 2026, buying an estimated $128K and bringing the position to 3,297 shares worth $1.74M. The position accounts for 0.06% of the portfolio, ranked #243.

GAMMA Investing first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.02M in Q4 2025. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • GAMMA Investing held 3,297 shares of Idexx Laboratories worth $1.74M as of Q2 2026.
  • GAMMA Investing bought 229 Idexx Laboratories shares in Q2 2026, an estimated $128K.
  • Idexx Laboratories made up 0.06% of GAMMA Investing's portfolio in Q2 2026, its #243 holding.
  • GAMMA Investing first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Idexx Laboratories position peaked at $2.02M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.